Bioresorbable ocular drug delivery device

US11318043B2 · kind B2 · utility

Assignee

• Dose Medical Corporation · US

Inventors

• Harold A. Heitzmann · Irvine, US
• David S. Haffner · Mission Viejo, US
• Kenneth M. Curry · San Clemente, US
• Thomas W. Burns · Dana Point, US

Key dates

• Filing date: Apr 20, 2017
• Grant date: May 3, 2022
• Expiry date: Sep 10, 2038

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61F2250/0068
• WIPO field: Medical technology
• WIPO sector: Instruments

Abstract

An ocular implant configured for implantation into the eye of a subject comprising an elongate outer shell (54), an internal plug (210) including a hydrogel and a drug reservoir including a drug (62) wherein the drug is configured to pass through at least a portion of the internal plug to control elution of the drug through the outer shell. The implant is made of biodegradable materials.